DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/sz483m/sustained_release) has announced the addition of the “Sustained Release Ocular Drug Delivery Systems, 2015 – 2025 (2nd edition)” report to their offering. …
Category: Business
Largest Prospective Study Evaluating the Effect of Vigabatrin on Vision
PHILADELPHIA–(BUSINESS WIRE)–The largest prospective study evaluating the effect of vigabatrin on vision will be available to view at the annual meeting of the American Epilepsy Society (AES) in Philadelphia.
Ocular Therapeutix™ to Present at the Piper Jaffray 27th Annual Healthcare Conference
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix™, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Amar Sawhney, Ph.D., President, Chief Executive Officer and Chairman, will participate in a fireside chat presentation at the Piper Jaffray 27th Annual Healthcare Conference on Wednesday, December 2, 2015 at 9:30 a.m. ET at The New York Palace Hotel in New York C
Ocular Therapeutix™ Begins Enrollment in its Second Phase 3 Clinical Trial for DEXTENZA™ for the Treatment of Allergic Conjunctivitis
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, announced today enrollment of the first patients in a second Phase 3 clinical trial to evaluate the safety and efficacy of DEXTENZA™ (sustained release dexamethasone), 0.4mg Intracanalicular Depot for the treatment of allergic conjunctivitis. DEXTENZA is a product candidate administer
Inotek Pharmaceuticals to Present at the Piper Jaffray 27th Annual Healthcare Conference
LEXINGTON, Mass.–(BUSINESS WIRE)–Inotek Pharmaceuticals to Present at the Piper Jaffray 27th Annual Healthcare Conference
Second Sight to Present at Piper Jaffray 27th Annual Healthcare Conference
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, announced today that Will McGuire, President and Chief Executive Officer, will present at the Piper Jaffray 27th Annual Healthcare Conference as follows: Date: Wednesday, December 2, 2015 Time: 3:00 p.m. EST Location: Lotte New York Palace
Watch the latest episode of BizWireTV from Business Wire
NEW YORK–(BUSINESS WIRE)–Watch the latest episode of BizWireTV from Business Wire
NovaBay Pharmaceuticals Announces Restructuring to Focus on Avenova Commercialization and Reports Third Quarter Financial Results
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay Pharmaceuticals Announces Restructuring to Focus on Avenova Commercialization and Reports Third Quarter Financial Results
RetroSense Therapeutics’ Clinical-Stage Development Program to Restore Vision Wins Multiple Awards
ANN ARBOR, Mich.–(BUSINESS WIRE)–Therapeutic Area Partnerships has selected RetroSense lead compound, RST-001, as a “Top Project to Watch: Most Licensable Products” and also won the “Deals of the Year” Research Award.
Aerpio Therapeutics Reports Positive Clinical Results from the Phase 2a Study of Lead Candidate, AKB-9778, in Diabetic Macular Edema (DME): The TIME-2 Trial
CINCINNATI–(BUSINESS WIRE)–Aerpio Therapeutics, Inc., a biopharmaceutical company focused on advancing first-in-class treatments for the eye, today announced that clinical data from the company’s phase 2a study of its lead candidate, AKB-9778, for the treatment of patients with DME, were reported in an oral presentation delivered by Peter Campochiaro, MD, from Johns Hopkins Wilmer Eye Institute, during the Retina Subspecialty Day at the ongoing American Academy of Ophthalmology (AAO) Annual M
Ophthotech Announces that Genentech, a Roche Wholly-Owned Subsidiary, Elects to Exercise Its Right to Opt-in to the Novartis Portion of the Ophthotech / Novartis Ex-US Agreement for Fovista® to Treat Wet Age-Related Macular Degeneration
NEW YORK–(BUSINESS WIRE)–Ophthotech announced that Genentech has elected to exercise its option to participate in the financial arrangements relating to Novartis’ rights under the Ophthotech/Novartis ex-US agreement.
New High Resolution Fundus Cameras VISUCAM 224 / 524 for More Confident Diagnosis
JENA, Germany & LAS VEGAS–(BUSINESS WIRE)–New high resolution Fundus Cameras VISUCAM 224 / 524 for more confident diagnosis; ZEISS introduces a new generation of high resolution Fundus cameras at the American Academy of Ophthalmology
ZEISS Presents Innovations That Support Ophthalmologists in Their Work
JENA, Germany & LAS VEGAS–(BUSINESS WIRE)–ZEISS presents innovations that support ophthalmologists in their work;
At the 2015 Annual Meeting of the American Academy of Ophthalmology (AAO) in Las Vegas, ZEISS announces innovations
Clarity Announces Commercial Availability of HOLOS IntraOpTM Technology
LAS VEGAS–(BUSINESS WIRE)–Clarity Medical Systems, Inc. (Clarity), a medical device company focused on the manufacture of integrated optical systems for the diagnosis and management of eye disorders, announces the commercial availability of its HOLOS…
Tobii AB: Tobii Receives Order for Eye-Tracking Platforms from MSI
STOCKHOLM–(BUSINESS WIRE)–Regulatory News: Tobii AB (Nasdaq Stockholm: TOBII) has received the first purchase order from Micro-Star International Co. Ltd (MSI) for its eye-tracking platform Tobii IS3. The platforms are to be used in premium gaming notebooks from MSI. Deliveries are planned to begin at the turn of 2015/2016. “This order is for integration of eye tracking in a high-end gaming notebook. This means that the initial volume is low, however it’s still an important milestone since it
Modernizing Medicine Showcases Built-in ICD-10 Coding and PQRS Reporting in EMA Ophthalmology EMR System at American Academy of Ophthalmology (AAO)
BOCA RATON, Fla.–(BUSINESS WIRE)–Modernizing Medicine will unveil the latest enhancements of EMA Ophthalmology at this year’s American Academy of Ophthalmology (AAO).
The Retina Group of Washington Selects Modernizing Medicine’s EMA Ophthalmology® EMR System to Streamline Physician Workflow and Improve Patient Care
BOCA RATON, Fla.–(BUSINESS WIRE)–Modernizing Medicine announced today that The Retina Group of Washington has selected EMA Ophthalmology to replace its legacy EMR solution.
NovaBay Pharmaceuticals Reschedules Third Quarter 2015 Conference Call to November 16
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay Pharmaceuticals will hold its third quarter 2015 investment community conference call on November 16 at 8:30 a.m. ET
Ocular Therapeutix™ Reports Third Quarter 2015 Financial Results
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix™, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced financial results for the third quarter ended September 30, 2015. “Our product development programs advanced meaningfully during the third quarter with an NDA submission to the Food and Drug Administration for our lead product candidate, DEXTENZA for a post-surgical o
Glaukos Corporation Announces Third Quarter 2015 Financial Results
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, …